Clinical Trials Browser

Phase 1/2 × Immunotherapy × 30 days × Clear all

NCT07595172 2026-05-19

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms